PET Imaging of Human Subjects, and Large and Small Animals


The MGH Gordon PET Core is cGMP/FDA registered PET drug manufacturer that operates at cost to provide investigators with required personnel, equipment and services to design and conduct research studies using positron emission tomography.

Services

Main services include:

  • Synthesis of radiotracers and radiopharmaceuticals
  • PET and SPECT animal and human imaging
  • Experimental design and pharmacokinetic modeling
  • Validation and regulatory submission of compound for human use
Radiopharmaceuticals Available for Human and Animal Use

The Core has synthesized over 20 compounds for clinical evaluation and routine use for neurology, cardiology and oncology. In addition, it has pioneered the use of 18F Tau imaging agents for neurodegenerative diseases such as Alzheimer’s disease and traumatic brain injuries.

F-18
FDG* (tumour metabolism/hypometabolism)
Florbetaben** (amyloid imaging)
Flutemetamol** (amyloid imaging)
Florbetapir** (amyloid imaging)
Fluciclovine** (tumor metabolism/prostate cancer imaging)
Sodium Fluoride** (bone imaging)
FES (estrogen receptor)†
Flortaucipir [T807] (tau protein)†
FPEB (mGlur5)‡
BFPET (myocardial perfusion) †
GE180 (TSPO/PBR)†
FLT (cellular proliferation)†
THK 5351/GE-216 (tau protein)†
FMISO (hypoxia)†
MK-6240 (tau protein) †
GE179 (NMDA receptor)‡

C-11
PiB (amlyoid)†
Altropane (Dopamine transport)‡
Raclopride (D2/D3 receptor imaging) †
Methionine (amino acid uptake)†
CO (gas for labeling red blood cells in vivo) ‡
Rolipram (PDE-4 receptor imaging) ‡
P943 (5-HT1B) ‡
PBR-28 (TSPO/PBR)† (S,S)-[11C]Methylreboxetine (MeNR/MRB)‡ – targets norepinephrine transporter

N-13
Ammonia*
N2 in Saline (lung perfusion imaging) ‡

Ga-68
DOTATATE** (neuroendocrine tumor imaging)

O-15
C15O2 (blood flow imaging) ‡

*FDA approved, MGH PET Center holds FDA marketing authorization
**FDA approved, available through local commercial nuclear pharmacies
†Active IND held by MGH Gordon PET Core
‡Available under Radioactive Drug Research Committee (RDRC) oversight

The MGH Gordon PET Core can validate a radiopharmaceutical for clinical research use. Please send inquiries to:
Daniel Yokell
Associate Director, Radiopharmacy and Regulatory Affairs, MGH Gordon PET Core.
Email: or Phone: 617-643-7541.

User Fees (effective from 10/1/2019 to 9/30/2020)

Services Internal User Fee for ​Non-Profit and Federal Sponsored Research (Direct Cost Internal User Fee for Industry Sponsored Research  External User Fee for ​Non-Profit and Federal Sponsored Research (Inclusive of Institutional Indirect Cost) External User Fee for Industry Sponsored Research
13N Ammonia Production + Imaging  $ 3,900 Contact us for rate  $ 5,616 Contact us for rate
13N2 PET GMP Production + Imaging  $ 2,800 Contact us for rate  $ 4,032 Contact us for rate
13N2 PET Production + Imaging  $ 1,350 Contact us for rate  $ 1,944 Contact us for rate  
13NH3 Cardiac Blood Flow  $ 3,700 Contact us for rate  $ 5,328 Contact us for rate
18F FDG Production + Imaging  $ 2,250 Contact us for rate    $ 3,240 Contact us for rate  
Other PET GMP Production + Imaging
(includes: 11C Compounds and 18F Compounds; excludes: 18F FDG, 13NH3, 13N2 and 13N Ammonia )
 $ 3,250 Contact us for rate  $ 4,680  Contact us for rate
Other PET Production + Imaging
(includes: 11C Compounds and 18F Compounds; excludes: 18F FDG, 13NH3, 13N2 and 13N Ammonia )
 $ 2,400 Contact us for rate  $ 3,456 Contact us for rate
PET Imaging Only (no dose, up to two hours)  $ 2,150 Contact us for rate  $ 3,096 Contact us for rate
Additional Imaging Time (per hour)  $  500 Contact us for rate  $  720 Contact us for rate
Phantom Imaging  $ 1,550 Contact us for rate  $ 2,232 Contact us for rate
PET Compound Dose (No Imaging)  $ 2,150 Contact us for rate  $ 3,096 Contact us for rate
Cyclotron Beam Time for Isotope Production (per hour)  $  950 Contact us for rate  $ 1,368 Contact us for rate
Micro PET Imaging Only (up to 2 hours)  $  450 Contact us for rate  $  648 Contact us for rate
Micro PET Additional Imaging Hour  $  140 Contact us for rate  $  202 Contact us for rate
Blood Processing  $ 1,200 Contact us for rate  $ 1,728 Contact us for rate
Consent Charge  $    100 Contact us for rate  $  144 Contact us for rate
CT  $  1,000 Contact us for rate  $ 1,440 Contact us for rate
IRB Renewal  $ 3,500 Contact us for rate  $ 5,040 Contact us for rate
Kinetic Modeling  $  1,100 Contact us for rate  $ 1,584 Contact us for rate
Radionuclidic Purity Testing  $  380 Contact us for rate  $  547 Contact us for rate
Regulatory Submission  $ 10,500 Contact us for rate  $ 15,120 Contact us for rate
SALSA Generator Validation  $ 2,800 Contact us for rate  $ 4,032 Contact us for rate
SPECT  $ 2,000 Contact us for rate  $ 2,880 Contact us for rate
SPECT-CT  $ 2,500 Contact us for rate  $ 3,600 Contact us for rate
Start-up Fee  $ 7,500 Contact us for rate  $ 10,800 Contact us for rate
Technician Training / Site Qualification (per hour)  $  300 Contact us for rate  $  432 Contact us for rate
Validation of Radiotracer for Animal Use  $ 15,000 Contact us for rate  $ 21,600 Contact us for rate
Validation of Radiotracer for Human and NHP Use  $ 27,000 Contact us for rate $ 38.880 Contact us for rate

Overhead Policy

An investigator using a Partners fund is considered an internal user and is subject to the overhead rate applied by his/her institution. The internal user fee is calculated based on the direct costs of providing each service. The external user fee comprises a direct fee negotiated with the PET Core plus an overhead component. The overhead rate set by Partners HealthCare is 44% for external academic users and 59% for external industry users.

Uncompleted Studies

The PET Core commits its best efforts to successfully complete scheduled studies. However, given the very nature of many PET studies that rely on manufacturing of radiopharmaceuticals and in vivo imaging, the Core cannot be held responsible for costs associated with incomplete studies due to equipment failure or circumstances outside of our control. 

Late Cancellation Policy

A PET study that is cancelled or rescheduled within five business days of the original imaging session may incur a fee up to the cost of the cancelled imaging session. A radiotracer production that is not cancelled 24 hours prior to the production day may incur a fee up to the cost of the produced dose.

Acknowledgement of Federal Funding

Measurement of radioactivity in blood and tissue samples uses state-of-the- art equipment acquired through the support of the NIH shared instrumentation grant S10OD018035. Users of our blood sampling and kinetic modeling services are encouraged to acknowledge the grant in their publications and to report it back to us.

The grant details are:

  • Project Number: S10OD018035
  • Title: Gamma Counter and Continuous Blood Sampler for Quantitative PET Imaging,
  • PIs: Georges El Fakhri, Marc Normandin,
Location

MGH Main Campus, Boston, MA: Edwards Basement (cyclotron, radiochemistry, and human and large animal imaging)
MGH Navy Yard Campus, Charlestown, 149 13th Street, Charlestown, MA (small animal imaging)

Major Equipment
  • GE Discovery PET/CT
  • Automated Radiochemical Synthesis systems
  • E.cam (Siemens) SPECT Systems and Planar Gamma Cameras
  • Exact HR+ Large Bore PET Scanner
  • NeuroPET/CT dedicated high sensitivity brain scanner
  • PC4096 Large Bore PET Scanner
  • Siemens PET/CT Scanner
  • Siemens Symbia SPECT/CT
  • VISTA small animal micro PET/CT
  • Tri-modality MicroPET-SPECT-CT
  • Perkin Elmer Wizard2 2480 gamma counter
  • Perkin Elmer Wizard 3860 gamma counter
  • Swisstrace Twilite II continuous blood counter